Léčivé přípravky s obsahem účinné látky Vedolizumab
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
30 / 100
Risk factors
Eligibility criteria and required documents are not specified, potentially hiding specific certifications or financial...
All submissions must be in Czech, which may limit participation.
Submission deadline in 6 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- CZK 41.2M estimated value
- Supplies contract
- 1 lot
- Duration 2 YEAR
- Supply of Vedolizumab 108MG injection solution in pre-filled pen
- Supply of Vedolizumab 300MG powder for concentrate for infusion solution
Show full summary
This tender is for the supply of Vedolizumab medicinal products (injection solution in pre-filled pen 108MG and powder for concentrate for infusion solution 300MG) to Krajská nemocnice Liberec, a.s. over a two-year period. The procedure is an open tender with a single lot, awarded solely on the lowest price. The estimated total value is 41,197,000 CZK. The submission deadline is 30 June 2026 at 08:00 CET.
Risks
Eligibility criteria and required documents are not specified, potentially hiding specific certifications or financial...
All submissions must be in Czech, which may limit participation.
Submission deadline in 6 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must supply both forms of Vedolizumab as described
Administrative
- Electronic submission required via Open portal
- Submission in Czech language only
Award Criteria
Lot 1
Buyer
Name
Krajská nemocnice Liberec, a.s.
Location
Liberec I - Staré Město, CZE
Buyer profile
Identifier
27283933
Lots (1)
LOT-0001
Léčivé přípravky s obsahem účinné látky Vedolizumab
Ongoing supply of Vedolizumab in two forms (108MG pre-filled pen and 300MG powder for infusion) based on partial orders over two years.
CZK 41.2M
Estimated value
Location
Duration
Category
Selection criteria
Deadline
Award details
Value note
Show original TED data
Original TED description
Předmětem veřejné zakázky jsou průběžné dodávky léčivých přípravků s obsahem účinné látky Vedolizumab jako injekční roztok v předplněném peru o síle 108MG, a jako prášek pro koncentrát pro infuzní roztok v injekční lahvičce o síle 300MG na základě dílčích objednávek vystavovaných dle aktuálních potřeb zadavatele po dobu dvou let.
Procurement Details
- Publication date
- 31 May 2026
- Notice type
- Contract notice — standard
- Languages
- Czech
Reference metadata
- Notice subtype
- 16
- Notice version
- 1
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 373742-2026
- Source notice ID
- 85d8afb3-3164-4a4b-ad16-743233978539
Documents (1)
Similar tenders
Poland – Antineoplastic agents – Dostawa produktów leczniczych i wyrobów medycznych do Wojskowego Instytutu Medycznego – PIB
Poland – Immunoglobulins – Dostawy produktów leczniczych, wyrobów medycznych oraz substancji do receptury
Poland – Immunosuppressive agents – Dostawa środków immunosupresyjnych, produktów leczniczych dla układu nerwowego, produktów leczniczych dla organów zmysłów, środków leczniczych dla układu oddechowego, produktów leczniczych dla przewodu pokarmowego i metabolizmu, produktów leczniczych stosowanych przy cukrzycy, insuliny, płynów dożylnych, ogólnoustrojowych preparatów hormonalnych, z wyłączeniem hormonów płciowych oraz różnych...
Czechia – Immunosuppressive agents – LP s obsahem certolizumab pegolu 2026
Czechia – Immunosuppressive agents – LP s obsahem risankizumabu 2026
Czechia – Immunosuppressive agents – Ixekizumab
Opportunity Score
Why this score?
Opportunity
70 / 100
Complexity
30 / 100
Risk factors
Eligibility criteria and required documents are not specified, potentially hiding specific certifications or financial...
All submissions must be in Czech, which may limit participation.
Submission deadline in 6 days
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications